Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plaquenil for unexplained recurrent pregnancy loss
2016-004981-24Phase 2Active
- Sponsor
- Henriette Svarre Nielsen
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in recurrent miscarriage (RPL) comparing Plaquenil with Placebo (2 arms). Primary endpoint: Live birth chance. Started Jan 2017; status: active.
02
Drugs
hydroxychloroquine
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on 2016-004981-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004981-24.